September 24, 2018

MMCRI Receives Funding to Study Opioid Prescribing Laws
The National Institutes of
Health (NIH) has awarded
Maine Medical Center’s research institute and its partnering institution, the University of Vermont (UVM),
a $339,000 grant to study
the impact that stricter opioid prescribing laws have
had on population health in
northern New England.
The research will be done
through the Northern New
England Clinical and Translational Research Network

(NNE-CTR), comprised of
researchers from the Maine
Medical Center Research
Institute (MMCRI) and
UVM, and funded by the
NIH.

opioids and make it more
difficult for patients to obtain prescriptions from multiple providers. Investigators Kathleen Fairfield,
MD, DrPH, of MMCRI and
the Department of MediIn 2016, Maine and Vermont responded to the opi- cine at Maine Medical
oid crisis with legislation
Center, and Valerie Harder,
instituting stricter opioid
PhD, MHS, and Timothy
prescribing guidelines and Plante, MD, MHS, of UVM
requirements for prescrip- will analyze whether that
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zations and other medical
events and whether there
were unintended consequences, such as patients
suffering from substance
use disorders turning instead to the illegal use of
heroin. The team also will
analyze whether outcomes
are different for various patient demographics, such as
whether they live in a rural
or urban area.
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LEFT: MMC’s Hospital Emergency Response Team (HERT)
triages actors portraying patients in a preparedness training exercise
simulating a mass casualty event following a hypothetical chemical
spill at a local manufacturing facility.
BELOW: Members of MMC’s Hospital Incident Command
System team coordinate the response to the mock mass casualty event
during last Thursday’s training drill.
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“This research provides us
the opportunity to study the
impact of state laws regarding opioid prescribing while
engaging with a wide variety
of community members in
real time,” said Dr. Fairfield. “We hope this work
will help inform clinical care
of patients, communitybased interventions, future
policy changes and additional research.”
The NIH awarded MMC
and UVM a $20 million research grant in 2017 to establish the NNE-CTR, a

regional network that would
help researchers develop
and implement innovative
medical treatments for
many chronic diseases prevalent in our region including
cancer, heart disease, obesity, diabetes, Alzheimer’s
disease and substance
abuse. Research activities
also focus on defining optimal methods of prevention
and health care delivery in
rural environments, where
approximately 60 percent of
Maine’s population resides. This grant provides
additional funds for the
NNE-CTR to focus specifically on the impact of the

opioid crisis on this
community.
“There is confidence the
program will provide options and opportunities for
development of a blueprint
to address opioid overdose,
with the potential to have a
powerful influence on addressing addiction in northern New England,” said
Clifford Rosen, MD, Director of the Center for Clinical and Translational Research at MMCRI and Principal Investigator, NNECTR. “The $339,000 grant
leverages the research infrastructure of the NNE-CTR
and will reinforce its reach

in a high-priority medical
challenge for our region and
beyond.”
“A decisive strength of the
program is our collaboration with colleagues at the
Maine Medical Center Research Institute,” said Gary
Stein, PhD, Principal Investigator, NNE-CTR and Director of the University of
Vermont Cancer Center.
“This new initiative
launched on September
1. The complementary institutional expertise will
have an impact locally, regionally and beyond.”

MMC Receives Recognition for Quality in Cardiac Care
Maine Medical Center has
been designated an Aetna
Institute of Quality® (IOQ)
Cardiac Care Facility for
Cardiac Medical Intervention, Cardiac Rhythm and
Cardiac Surgery Programs.
IOQ-designated Cardiac
Care Facilities meet evidence-based and recognized
standards for clinical outcomes, processes of care
and patient safety, according to Aetna. Factors
weighed in designating the
IOQ facilities include Board
certification, participation in
quality improvement surveys and low mortality,
morbidity and readmission
rates, among other criteria.
IOQ Cardiac Care Facilities
also need to meet cost-

efficiency standards.

of our physicians and staff,”
“This designation validates said Douglas B. Sawyer,
MD, Chief Cardiovascular
Maine Medical Center’s
continuous commitment to Services and Physician Lead
for Maine Medical Center
quality patient care. It is a
testament to the dedication Cardiovascular Service Line.

Aetna makes information
about the quality and cost
of health care services available to its members to help
them make informed decisions about their health care
needs.

